{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:13:43Z","timestamp":1788671623502,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.alit.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T21:33:57Z","timestamp":1764624837000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discrepancies between the asthma control test and quality of life scores among biologic- and nonbiologic-treated asthma patients"],"prefix":"10.1016","volume":"75","author":[{"given":"Hironobu","family":"Sunadome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Maetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7481-0212","authenticated-orcid":false,"given":"Naoya","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyasu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.11.003_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.alit.2019.06.003","article-title":"Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.11.003_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/23120541.00122-2024","article-title":"Epidemiology of patients with severe asthma in Japan: a nationwide descriptive study","volume":"10","author":"Kimura","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.alit.2025.11.003_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.anai.2024.05.003","article-title":"Asthma control in the United States: relationships between short-acting \u03b22-agonist and systemic corticosteroid use","volume":"133","author":"Chupp","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI biologicals guidelines-recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.11.003_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S2213-2600(24)00242-X","article-title":"Patient-reported outcomes: missing in asthma remission","volume":"12","author":"Chan","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2025.11.003_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.anai.2011.09.001","article-title":"Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria","volume":"107","author":"Korn","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.chest.2023.04.028","article-title":"Are we ready for asthma remission as a clinical outcome?","volume":"164","author":"Lugogo","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.alit.2025.11.003_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2025.11.003_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.anai.2023.08.609","article-title":"Consensus of an American college of allergy, asthma, and immunology, American academy of allergy, asthma, and immunology, and American thoracic society workgroup on definition of clinical remission in asthma on treatment","volume":"131","author":"Blaiss","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1020897816228","article-title":"Health-related quality of life in asthma: a comparison between the St George\u2019s respiratory questionnaire and the asthma quality of life questionnaire","volume":"11","author":"Sanju\u00e1s","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.alit.2025.11.003_bib12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.21037\/atm-22-5918","article-title":"Independent risk factors of asthma exacerbations: 3-Year follow-up in a single-center prospective cohort study","volume":"10","author":"He","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.alit.2025.11.003_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1440-1843.2011.02105.x","article-title":"Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations","volume":"17","author":"Ko","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.alit.2025.11.003_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3346\/jkms.2008.23.4.621","article-title":"Correlation between the Korean version of asthma control test and health-related quality of life in adult asthmatics","volume":"23","author":"Kwon","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.alit.2025.11.003_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12054","article-title":"Predictors of asthma-related quality of life in a large cohort of asthmatics: a cross-sectional study in a secondary care center","volume":"11","author":"Louis","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.alit.2025.11.003_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01231-2022","article-title":"Identifying and appraising outcome measures for severe asthma: a systematic review","volume":"61","author":"Rattu","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.11.003_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13223-015-0074-0","article-title":"The role of flavor and fragrance chemicals in TRPA1 (transient receptor potential cation channel, member A1) activity associated with allergies","volume":"11","author":"Mihara","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib19","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1038\/s41467-022-31491-1","article-title":"Cigarette smoke aggravates asthma by inducing memory-like type 3 innate lymphoid cells","volume":"13","author":"Ham","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2025.11.003_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2022.11.021","article-title":"Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis","volume":"151","author":"Nopsopon","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.anai.2022.12.018","article-title":"A comparison of the effectiveness of biologic therapies for asthma: a systematic review and network meta-analysis","volume":"130","author":"Pitre","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2025.11.003_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","article-title":"Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: a prospective, observational study","volume":"73","author":"Tajiri","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.11.003_bib24","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1111\/bph.15240","article-title":"Targeting IL-5 pathway against airway hyperresponsiveness: a comparison between benralizumab and mepolizumab","volume":"177","author":"Calzetta","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.alit.2025.11.003_bib25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.202307-1266OC","article-title":"Increased Muc5AC and decreased ciliated cells in severe asthma partially restored by inhibition of IL-4R\u03b1 receptor","volume":"210","author":"Boomer","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.11.003_bib26","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jaci.2008.09.022","article-title":"Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to TH2-type immune responses and airway inflammation","volume":"122","author":"Nakamura","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep39559","article-title":"Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption","volume":"6","author":"Dong","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2025.11.003_bib28","doi-asserted-by":"crossref","DOI":"10.2196\/19006","article-title":"Mobile health app for Japanese adult patients with asthma: clinical observational study","volume":"22","author":"Harada","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.alit.2025.11.003_bib29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.anai.2023.03.001","article-title":"Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma","volume":"130","author":"Chipps","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.11.003_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a european respiratory society\/american thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.11.003_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1081\/JAS-120018634","article-title":"The prevalence of airways hyperresponsiveness in members of an exercise training facility","volume":"40","author":"Mannix","year":"2003","journal-title":"J Asthma"},{"key":"10.1016\/j.alit.2025.11.003_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.resinv.2016.07.002","article-title":"\u201cCold air\u201d and\/or \u201ctalking\u201d as cough triggers, a sign for the diagnosis of cough variant asthma","volume":"54","author":"Kanemitsu","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.alit.2025.11.003_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1513\/AnnalsATS.201608-616BC","article-title":"Risks and cough-aggravating factors in prolonged cough epidemiological observations from the Nagahama cohort study","volume":"14","author":"Matsumoto","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.alit.2025.11.003_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-2600(23)00187-X","article-title":"Cough and cough hypersensitivity as treatable traits of asthma","volume":"11","author":"Lai","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2025.11.003_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02583-2021","article-title":"Asthma remission: what is it and how can it be achieved?","volume":"60","author":"Thomas","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.11.003_bib36","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jaip.2023.05.047","article-title":"Response to biologics and clinical remission in the adult German asthma net severe asthma registry cohort","volume":"11","author":"Milger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.11.003_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.anai.2025.06.017","article-title":"Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab","volume":"135","author":"Hamada","year":"2025","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:44:34Z","timestamp":1774543474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893025001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1323893025001200"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.11.003","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancies between the asthma control test and quality of life scores among biologic- and nonbiologic-treated asthma patients","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}